Chong Qiu | Nanomedicine | Young Scientist Award

Published on by Young Scientists Awards

Assoc Prof Dr. Chong Qiu | Artificial Intelligence | Young Scientist Award

Associate Professor at China Academy of Chinese Medical Sciences, China

Dr. Chong Qiu is an Associate Professor at the Artemisinin Research Center and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences. He earned his PhD from Peking University, specializing in nanocarriers for drug delivery, siRNA, and peptide therapeutics. Dr. Qiu’s research focuses on innovative nanoparticle-based drug delivery systems, with applications in cancer treatment, pulmonary fibrosis, and targeted gene therapies. His work is widely recognized, with numerous high-impact publications in prestigious journals like Nature Communications and Journal of Nanobiotechnology. He is also a board member of several scientific journals and a leading expert in his field.

Publication profile

Education:

  • PhD in Pharmaceutical Science, Peking University, 2019
  • Bachelor’s degree, Peking University, 2014

Research Interests:

  • Nanocarriers for siRNA delivery
  • Nano-carriers for oral protein and peptide
  • Targeted nanoparticulate drug delivery

Professional Roles:

  • Young Scientist Board Member for Asian Journal of Pharmaceutical Sciences, iMeta, and Traditional Medicine Research and Exploration

Publication

  1. Photoaffinity probe-based antimalarial target identification of artemisinin in the intraerythrocytic developmental cycle of Plasmodium falciparum
    Journal: iMeta
    Year: 2024
    DOI: 10.1002/IMT2.176
    Contributors: Gao, Peng; Wang, Jianyou; Qiu, Chong; Zhang, Huimin; Wang, Chen; Zhang, Ying; Sun, Peng; Chen, Honglin; Wong, Yin Kwan; Chen, Jiayun et al.

 

  1. Enhanced tumor penetration across the blood-brain barrier: endoplasmic reticulum membrane hybrid siRNA nanoplexes
    Journal: Materials Today Nano
    Year: 2024
    DOI: 10.1016/j.mtnano.2023.100442
    Contributors: Chong Qiu; Shun Tao Liang; Qing Chao Tu; Chen Pan; Jia Yin Han; Bo Wu; Qiu Yan Guo; Yu Qian Lu; Jun Zhe Zhang; Yu Qing Meng et al.

 

  1. Advanced Strategies for Overcoming Endosomal/Lysosomal Barrier in Nanodrug Delivery
    Journal: Research
    Year: 2023
    DOI: 10.34133/RESEARCH.0148
    Contributors: Qiu, Chong; Xia, Fei; Zhang, Junzhe; Shi, Qiaoli; Meng, Yuqing; Wang, Chen; Pang, Huanhuan; Gu, Liwei; Xu, Chengchao; Guo, Qiuyan et al.

 

  1. Advanced strategies for nucleic acids and small-molecular drugs in combined anticancer therapy
    Journal: International Journal of Biological Sciences
    Year: 2023
    DOI: 10.7150/ijbs.79328
    Contributors: Chong Qiu; Yanyan Wu; Qiaoli Shi; Qiuyan Guo; Junzhe Zhang; Yuqing Meng; Chen Wang; Fei Xia; Jigang Wang; Chengchao Xu

 

  1. Anemoside B4 alleviates neuropathic pain through inhibiting inflammation
    Source: ResearchSquare
    Year: 2022
    DOI: 10.21203/rs.3.rs-1821028
    Contributors: Zhao, M.; Li, H.; Yang, T.; Qiu, C.; Lu, T.; Wang, Q.; Guo, Q.; Wang, J.

 

  1. Preparation and application of calcium phosphate nanocarriers in drug delivery
    Journal: Materials Today Bio
    Year: 2022
    DOI: 10.1016/j.mtbio.2022.100501
    Contributors: Chong Qiu; Yanyan Wu; Qiuyan Guo; Qiaoli Shi; Junzhe Zhang; Yuqing Meng; Fei Xia; Jigang Wang

 

🏆 Conclusion

Dr. Chong Qiu is highly suitable for a Young Scientist Award. His innovative research, strong publication record, and leadership roles in the field of nanotechnology-based drug delivery make him a compelling candidate. With some strategic improvements in expanding research impact and fostering international collaborations, he has the potential to significantly advance the scientific community’s understanding of targeted therapeutics.

 

Julien Olivet | Epigenetics | Young Scientist Award

Published on by Young Scientists Awards

Dr.Julien Olivet | Epigenetics | Young Scientist Award

Dr Julien Olivet Rega Institute/KU Leuven Belgium

Julien Olivet is an exceptional candidate for the Young Scientist Award due to his innovative research in structural and chemical biology, leadership in managing research projects, and significant international recognition. His technical expertise, particularly in cryo-EM and drug discovery, stands out. Additionally, his commitment to teaching and science outreach is commendable. To strengthen his candidacy, he could emphasize the real-world impact of his research and diversify his research topics and publications. Overall, Julien’s achievements and contributions make him a highly deserving nominee for the award.

Publication profile

scholar

🎓 Education

PhD in Biochemistry, Molecular and Cellular Biology, Bioinformatics and ModelingUniversité de Liège, Belgium (2015-2021)Thesis: Selective disruption of histone deacetylase complexes by small-molecule inhibitors.MSc in Chemistry of Life and NanomaterialsUniversité de Namur, Belgium (2013-2015)Thesis: Synthesis of alginate/SiO2-TiO2 hybrid material for cell encapsulation.BSc in ChemistryFacultés Universitaires Notre-Dame de la Paix, Namur, Belgium (2009-2013).High School Diploma in Mathematics, Sciences Institut Notre-Dame de Loverval, Belgium (2003-2009).

🔬 Research Experience

Postdoctoral Fellow, KU Leuven (09/2021-present),Focus: Cryo-EM structures of SIN3 histone deacetylase (HDAC) complexes, managing collaborations, drug design.Visiting Senior Scientist, Université de Liège (09/2021-present)Focus: Inhibitors of SIN3 protein in HDAC complexes, drug screening, spin-off development.PhD Research Fellow, Université de Liège (01/2021-06/2021)Focus: Small molecule screening pipelines, virus-host interactions.Visiting FRS-FNRS/WBI PhD Research Fellow, Harvard Medical School (11/2015-12/2020)
Focus: Chemical genetic selections, protein interaction assays.

🏆 Honours and Awards

NSFC-FWO Collaboration Project Award (2024-2025),Research Foundation Flanders (FWO), Belgium.McKinsey & Company Scientific Award (2022)EUR 5000.Marie Skłodowska-Curie Actions (MSCA) European Postdoctoral Fellowship (2022-2024),EUR 191760.Best Oral Presentation Award (2019)Dana-Farber Cancer Institute, USA.

Publication

  • Maximizing binary interactome mapping with a minimal number of assays
    • Authors: SG Choi, J Olivet, P Cassonnet, PO Vidalain, K Luck, L Lambourne, …
    • Year: 2019
  • The HTLV-1 viral oncoproteins Tax and HBZ reprogram the cellular mRNA splicing landscape
    • Authors: C Vandermeulen, T O’Grady, J Wayet, B Galvan, S Maseko, M Cherkaoui, …
    • Year: 2021
  • Alternative glycosylation controls endoplasmic reticulum dynamics and tubular extension in mammalian cells
    • Authors: D Kerselidou, BS Dohai, DR Nelson, S Daakour, N De Cock, …
    • Year: 2021
  • A systematic approach to identify host targets and rapidly deliver broad-spectrum antivirals
    • Authors: J Olivet, SB Maseko, AN Volkov, K Salehi-Ashtiani, K Das, …
    • Year: 2022
  • AI-guided pipeline for protein–protein interaction drug discovery identifies a SARS-CoV-2 inhibitor
    • Authors: P Trepte, C Secker, J Olivet, J Blavier, S Kostova, SB Maseko, I Minia, …
    • Year: 2024
  • Identification of small molecule antivirals against HTLV-1 by targeting the hDLG1-Tax-1 protein-protein interaction
    • Authors: SB Maseko, Y Brammerloo, I Van Molle, A Sogues, C Martin, C Gorgulla, …
    • Year: 2023
  • A quantitative mapping approach to identify direct interactions within complexomes
    • Authors: P Trepte, C Secker, SG Choi, J Olivet, ES Ramos, P Cassonnet, S Golusik, …
    • Year: 2021
  • Expanding the HDAC druggable landscape beyond enzymatic activity
    • Authors: J Olivet, SG Choi, S Sierra, TM O’Grady, M de la Fuente Revenga, F Laval, …
    • Year: 2023
  • Interactome and structural basis for targeting the human T-cell leukemia virus Tax oncoprotein
    • Authors: SB Maseko, I Van Molle, K Blibek, C Gorgulla, J Olivet, J Blavier, …
    • Year: 2021
  • The viral oncoproteins Tax and HBZ reprogram the cellular mRNA splicing landscape
    • Authors: C Vandermeulen, T O’Grady, B Galvan, M Cherkaoui, A Desbuleux, …
    • Year: 2021
  • Structural basis for targeting the human T-cell leukemia virus Tax oncoprotein and syntenin-1 interaction using a small molecule
    • Authors: SB Maseko, I Van Molle, K Blibek, C Gorgulla, J Olivet, J Blavier, …
    • Year: 2021
  • Selective disruption of histone deacetylase complexes by small-molecule inhibitors of protein interactions
    • Author: J Olivet
    • Year: 2021

 

🏅 Conclusion

Julien Olivet is a strong candidate for the Young Scientist Award due to his outstanding research achievements, leadership skills, and contributions to the scientific community. His innovative work in cryo-EM and drug discovery, combined with his active role in mentoring and outreach, aligns well with the criteria for the award. Addressing the areas for improvement, particularly in demonstrating the broader impact of his research and expanding his publication portfolio, could further solidify his candidacy.

Daniele Florio | Pharmaceutical science | Young Scientist Award

Published on by Young Scientists Awards

Mr. Daniele Florio | Pharmaceutical science | Young Scientist Award

Daniele Florio is a dedicated researcher in pharmaceutical sciences, currently pursuing a Ph.D. at the University of Naples Federico II. His doctoral work focuses on integrated molecular approaches targeting mutated Nucleophosmin 1 in Acute Myeloid Leukemia, scheduled for completion in October 2024. Daniele brings extensive experience from his Marie Sklodowska-Curie secondment and voluntary internship, specializing in peptide synthesis, mass spectrometry, and spectroscopic techniques. With a strong publication record and active participation in international conferences, he contributes significantly to the fields of amyloid aggregation, chemical catalysis, and drug development, showcasing advanced skills in scientific research and analysis.

Profile

Scopus

👨‍🏫Professional Experience

Tutoring Activities (Grant Type B) 2023-2024, Naples, Italy, Department of Pharmacy, University of Naples Federico II, Provided supplementary teaching for Chemistry and Inorganic Chemistry courses for Pharmacy and CTF degree students. Ph.D. Candidate in Pharmaceutical Sciences (XXXVII Cycle) 2021 – Present, Naples, Italy, Department of Pharmacy, University of Naples Federico II, PhD Project: Integrated molecular approaches targeting mutated Nucleophosmin 1 in Acute Myeloid Leukemia., Scheduled PhD end: October 31, 2024. Secondee under Marie Skłodowska-Curie Research and Innovation Staff Exchange Action June 2022 – March 2023, Dublin, Ireland, Keladapharmachem, Participated in the GreenX4Drug (EU funded H2020 RISE project), focusing on developing novel asymmetric chemical catalysts for manufacturing high-value APIs and advanced intermediates.. Voluntary Internship Post-Degree 2018 – 2019, Naples, Italy, Department of Pharmacy, University of Naples Federico II, Designed, synthesized, and characterized peptides, peptidomimetics, and small molecules using solid-phase and solution methodologies. Utilized mass spectrometry (ESI) for identifying synthetic compounds and applied analytical and preparative methodologies (HPLC) for their purification and characterization. Conducted structural and functional characterization of biomolecules through spectroscopic techniques (CD, Fluorescence, SPR, UV-Vis). Supervisor: Prof. Daniela Marasco

🎓Education and Training

Biologist Board Examination February 7, 2022, University of Naples Federico II, Naples, Italy Master’s Degree in Biological Science (Molecular Diagnostics Field) July 12, 2021, Naples, Italy Department of Pharmacy, University of Naples Federico II Experimental Thesis: “Protein fragments of Nucleophosmin 1 as models of amyloids”, Supervisor: Prof. Antonello Merlino, Co-Supervisor: Prof. Daniela Marasco,k Grade: 110/110. Bachelor’s Degree in Biological Science (Molecular Diagnostics Field) March 15, 2018, Naples, Italy Department of Pharmacy, University of Naples Federico II Experimental Thesis: “Amyloid-like aggregation of Nucleophosmin 1 regions related to Acute Myeloid Leukemia: spectroscopic studies” Supervisor: Prof. Daniela Marasco Grade: 106/110

📖Certifications

English TELSA C1, Grade B Language Certification ESAT, Malta Further & Higher Education Authority

Skills and Competencies

Organizational Skills

  • Efficient under pressure.
  • Adaptive to changes and new situations.
  • Strong independent work organization and goal achievement.

Job-related Skills

  • Solid-phase peptide synthesis and combinatorial peptide libraries using Fmoc/Boc chemistry.
  • Experience with various peptide synthesizers (BIOTAGE, Liberty Blue 2.0).
  • Proficient in analysis and purification using ESI mass spectrometry, HPLC, and flash purification systems.
  • Skilled in spectroscopic techniques (CD, Fluorescence, DLS, SPR, UV-Vis, FTIR, NMR).

Digital Skills

  • Proficient in Microsoft Office Suite.
  • Experienced with operating systems: MS-Windows, MacOS, LINUX.
  • Proficient in scientific data analysis software (GraphPad Prism).
  • Knowledgeable in databases (PubMed) and bibliographic management software (EndNote, Mendeley).
  • Proficient with video conferencing software (Teams, Skype, Zoom, Google Meet).
  • Excellent knowledge of major browsers (Edge, Chrome, Firefox, Safari, Opera).

🌍Projects

National Project Participation

  • BANDO-PRIN-2022. Research Project: Design, synthesis, and investigation of novel G-quadruplex aptamers against STAT3 and the interleukin-6 receptor (G4-APTASTAT).
  • Project Coordinator and Head of Research Unit: Prof. GALEONE Aldo

Bibliometric Parameters

  • H-index from Scopus: 11
  • Number of Publications: 24
  • Citations: 388

 

Publications Top Notes 📝

  • The effects of histidine substitution of aromatic residues on the amyloidogenic properties of the fragment 264–277 of nucleophosmin 1
    • Authors: D. Florio, P. Luciano, C. Di Natale, D. Marasco
    • Journal: Bioorganic Chemistry
    • Volume: 147
    • Year: 2024
    • Pages: 107404

 

  • Could Targeting NPM1c+ Misfolding Be a Promising Strategy for Combating Acute Myeloid Leukemia?
    • Authors: D. Florio, D. Marasco
    • Journal: International Journal of Molecular Sciences
    • Volume: 25
    • Issue: 2
    • Year: 2024
    • Pages: 811

 

  • Modulation of hydrogel networks by metal ions
    • Authors: S. La Manna, D. Florio, C. Di Natale, D. Marasco
    • Journal: Journal of Peptide Science
    • Volume: 29
    • Issue: 8
    • Year: 2023
    • Article ID: e3474

 

  • Ruthenium complexes bearing glucosyl ligands are able to inhibit the amyloid aggregation of short histidine-peptides
    • Authors: D. Florio, S. La Manna, A. Annunziata, M. Monti, D. Marasco
    • Journal: Dalton Transactions
    • Volume: 52
    • Issue: 25
    • Year: 2023
    • Pages: 8549–8557

 

  • Insights into Network of Hot Spots of Aggregation in Nucleophosmin 1
    • Authors: D. Florio, S. La Manna, C. Di Natale, A.M. Malfitano, D. Marasco
    • Journal: International Journal of Molecular Sciences
    • Volume: 23
    • Issue: 23
    • Year: 2022
    • Pages: 14704

 

  • Hydrogelation tunability of bioinspired short peptides
    • Authors: S. La Manna, D. Florio, V. Panzetta, C. Di Natale, D. Marasco
    • Journal: Soft Matter
    • Volume: 8
    • Year: 2022
    • Pages: 8

 

fahimeh nasimi | biomedical signal processing | Best Researcher Award

Published on by Young Scientists Awards

Dr. fahimeh nasimi | biomedical signal processing | Best Researcher Award

A proactive and innovative researcher with expertise in deep learning and machine learning applications, specializing in cardiac arrhythmia detection algorithms. With a Ph.D. in Computer Engineering and extensive experience as an Assistant Professor at the University of Isfahan-Khansar Campus, I excel in strategic problem-solving and decision-making. Known for maintaining composure under pressure and fostering collaborative environments, I am committed to advancing knowledge through hands-on research and effective team leadership. My career highlights include significant contributions to wireless body area networks and a strong record of academic excellence, including top rankings during both my B.Sc. and M.Sc. studies at Isfahan University.

Profile

  1. Scopus

 

  1. Orcid

📈Core Qualifications

Proactive Researcher: Extensive experience in conducting independent research with a proactive approach.. Strategic and Creative Thinking: Strong problem-solving skills, capable of developing innovative strategies by thinking outside the box. Decision Making: Skilled in making informed decisions and taking responsibility for outcomes. Even Temperament: Ability to maintain composure and handle situations calmly, regardless of challenges. Learning by Doing: A continuous learner who thrives on hands-on experience and practical learning. Collaboration & Team Building: Proficient in fostering collaborative environments and building effective teams.

Technical Skills

Programming Languages: C, C++, MATLAB, Python, Advanced Skills: Deep Learning, Machine Learning, Software Proficiency: ICDL, Cisco Packet Tracer, Linux (Ubuntu)

💼Professional Experience

Assistant Professor, University of Isfahan-Khansar Campus. Since September 2023 University Lecturer (Part-time) University of Isfahan January 2021 – 2023. Visiting Researcher University of South Australia September 2017 – March 2018 Research Assistant University of Isfahan 2014 – 2023

🎓Education

  • Postdoc Researcher, Department of Biomedical Engineering
    • Faculty of Engineering, University of Isfahan
    • Isfahan, Iran
    • 2020 – 2023
  • Ph.D. in Computer Engineering
    • Faculty of Computer Engineering, University of Isfahan
    • Isfahan, Iran
    • 2014 – 2020
    • Thesis: Improving Intra-nodes Communication Power Consumption in Wireless Body Area Networks
  • Master in Computer Engineering – Computer Systems Architecture
    • Faculty of Computer Engineering, University of Isfahan
    • Isfahan, Iran
    • 2011 – 2013
  • Bachelor in Computer Engineering – Computer Hardware
    • Department of Computer Engineering, Faculty of Engineering, University of Isfahan
    • Isfahan, Iran
    • 2005 – 2009

🏫Employment History

  • Assistant Professor
    • University of Isfahan-Khansar Campus
    • September 2023 – Present

🔬Research Focus

My research interests primarily focus on designing novel algorithms using deep learning techniques for the detection of cardiac arrhythmias. This interest was sparked during my postdoctoral research and continues to evolve in my current role, where I am dedicated to addressing challenges associated with identifying similar types of arrhythmias.

🏆 Awards and Honors 

Ranked 3rd, B.Sc. students, Isfahan University, 2009. Ranked 2nd, M.Sc. students, Isfahan University, 2014

Publications Top Notes 📝

  • Title: Green Communication in wireless network
    • Authors: Ehdieh Khaledian, Fahimeh Nasimi, Naser Movahedinia
    • Conference: ETEC (Emerging Trends in Energy Conservation), 2013

 

  • Title: A survey on energy consumption reduction techniques in WBAN
    • Authors: Fahimeh Nasimi, Naser Movahedinia, Mohammad Reza Khayyambashi
    • Conference: CITCONF, 2017

 

  • Title: Exploiting Similar Prior Knowledge for Compressing ECG Signals
    • Authors: Fahimeh Nasimi, Naser Movahhedinia, Mohammad Reza Khayyambashi, Yee Wei Law
    • Journal: Biomedical Signal Processing and Control (Elsevier), 2020
    • Year: 2020

 

  • Title: Redundancy cancellation of compressed measurements by QRS complex alignment
    • Authors: Nasimi Fahimeh, Mohammad Reza Khayyambashi, Naser Movahhedinia
    • Journal: Plos one
    • Volume: 17
    • Issue: 2
    • Year: 2022
    • Article ID: e0262219

 

  • Title: LDIAED: A lightweight deep learning algorithm implementable on automated external defibrillators
    • Authors: Nasimi Fahimeh, Mohammadreza Yazdchi
    • Journal: Plos one
    • Volume: 17
    • Issue: 2
    • Year: 2022
    • Article ID: e0264405

 

  • Title: A novel spatio-temporal convolutional neural framework for multimodal emotion recognition
    • Authors: Sharafi Masoumeh, Mohammadreza Yazdchi, Reza Rasti, Fahimeh Nasimi
    • Journal: Biomedical Signal Processing and Control
    • Volume: 78
    • Year: 2022
    • Pages: 103970

 

Teng Zhang | Gynecologic Oncology | Young Scientist Award

Published on by Young Scientists Awards

Ms. ‌Teng Zhang |Gynecologic Oncology |Young Scientist Award 

Ms at Qilu Hospital of Shandong University, China

Ms. Teng Zhang is an accomplished Attending Doctor in the Department of Obstetrics and Gynecology at Qilu Hospital of Shandong University. With a Ph.D. and Master’s degree from Cheeloo College of Medicine, Shandong University, and a Bachelor’s degree from Jining Medical College, Ms. Zhang has extensive experience in clinical practice and research. Notable achievements include publications on cervical cancer in high-impact journals and awards in English teaching competitions. Dr. Zhang’s research focuses on fertility-sparing treatments, m6A methylation, and immune cell variations in cervical cancer, underscoring a strong commitment to advancing women’s health.

Profile

 

🎓 Education Background

Sept. 2015 – Sep. 2018: Ph.D., Cheeloo College of Medicine, Shandong University. Sept. 2013 – Sep. 2015: Master, Cheeloo College of Medicine, Shandong University. Sept. 2008 – Jun. 2013: Bachelor of Medicine, Jining Medical College. Sept. 2005 – Jun. 2008: Qingdao No.2 Middle School

💼 Research/Work Experience

July 2022 – Present: Attending Doctor, Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University. Nov. 2018 – June 2021: Resident, Department of Gynecology and Obstetrics, Qilu Hospital of Shandong University. June 2016 – June 2017: Visiting Scholar, Griffith University, Australia

🏆 Scholarships and Awards

2023: Young Teachers English Teaching Competition, Second Prize, Cheeloo College of Medicine, Shandong University, 2021: The First “Guangzhi Cup” English Teaching Competition in Qilu Hospital of Shandong University, Third Prize, July 2013: Excellent Graduate of Shandong Province, Oct. 2009: National Scholarship

Publications Top Notes 📝

  • Xuji Jiang, Chuanli Feng, Wanying Sun, Teng Zhang*, Baoxia Cui. “The top 100 most cited articles on fertility-sparing treatments for cervical cancer: A bibliometric analysis.” Heliyon, 10(11), 2024.

 

  • Zhonghao Mao, Bingyu Wang, Teng Zhang, Baoxia Cui*. “The roles of m6A methylation in cervical cancer: functions, molecular mechanisms, and clinical applications.” Cell Death and Disease, 2023, 14(734).

 

  • Teng Zhang, Jun Jiao, Xinlin Jiao, Lu Zhao, Xinli Tian, Qing Zhang, Daoxin Ma, Baoxia Cui*. “Aberrant frequency of TNFR2+ Treg and related cytokines in patients with CIN and cervical cancer.” Oncotarget, 2017, 9(4).

 

  • Bingyu Wang, Zhonghao Mao, Jinwen Ye, Xinlin Jiao, Teng Zhang, Qi Wang, Sai Han, Youzhong Zhang, Chunling Wang, Taotao Dong, Baoxia Cui. “Glycolysis Induced by METTL14 Is Essential for Macrophage Phagocytosis and Phenotype in Cervical Cancer.” The Journal of Immunology, 2024, 15(212).

 

  • Zhang W, Tian X, Mumtahana F, Jiao J, Zhang T, Croce K.D., Cui B*. “The existence of Th22, pure Th17 and Th1 cells in CIN and Cervical Cancer along with their frequency variation in different stages of cervical cancer.” BMC Cancer, 2015, 15,717.

 

  • Jun Jiao, Teng Zhang, Xinlin Jiao, Tingting Huang, Lu Zhao, Daoxin Ma, Baoxia Cui*. “hsa_circ_0000745 promotes cervical cancer by increasing cell proliferation, migration, and invasion.” J Cell Physiol, 2019, 1-9.

 

  • Xinlin Jiao, Siying Zhang, Jun Jiao, Teng Zhang, Wenjie Qu, Guy Mutangala Muloye, Beihua Kong, Qing Zhang, Baoxia Cui*. “Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance.” Clin Epigenetics, 2019, 11(120).

 

 

Faiyaz Shakeel |Pharmaceutical sciences | Best Researcher Award

Published on by Young Scientists Awards

 Prof Dr. Faiyaz Shakeel | Pharmaceutical sciences |Best Researcher Award

Prof Dr. King Saud University, Saudi Arabia

👩‍🔬Highly accomplished in pharmaceutics, holds a Ph.D. and M. Pharm. from Jamia Hamdard University, India. With extensive experience as a Professor and Associate Professor at King Saud University, Riyadh, Saudi Arabia, and previous roles in academia and research, he excels in formulation research and development. His expertise spans nanoemulsions and transdermal dosage forms, contributing significantly to the field. Driven by a passion for innovation, he led groundbreaking projects, optimizing drug delivery systems for enhanced therapeutic outcomes. Eager to leverage his skills and knowledge, he seeks to join a renowned research organization, fostering growth and advancement in pharmaceutical sciences.🌟

 

Profile

 

Scholar

 

🎓  Objectives

Seeking association with a renowned research organization in formulation research and development to upgrade knowledge, research, and management skills in line with the latest trends. Eager to be part of a dynamic team contributing to organizational growth.

📚  Qualification Overview

Doctor of Philosophy (Ph.D.) in Pharmaceutics, Jamia Hamdard University, New Delhi, India, 2004-2007. Master of Pharmacy (M. Pharm.) in Pharmaceutics, Jamia Hamdard University, New Delhi, India, 2002-2004. Bachelor of Pharmacy (B. Pharm.), Jamia Hamdard University, New Delhi, India, 1998-2002.

👨‍🏫 Professional Experience

Professor, King Saud University, Riyadh, Saudi Arabia (Feb 2022 – Present) Associate Professor, King Saud University, Riyadh, Saudi Arabia (Mar 2016 – Feb 2022) Assistant Professor, King Saud University, Riyadh, Saudi Arabia (Nov 2011 – Mar 2016) Lecturer, Garyounis University, Benghazi, Libya (Nov 2007 – Nov 2011) Senior Lecturer, Bhawani Shankar Anangpuria Institute of Pharmacy, Faridabad, India (Aug 2006 – Oct 2007) Guest Lecturer, Shri Gopichand College of Pharmacy, Baghpat, India (Jul 2004 – Jun 2006)

🏅  Professional Qualification

Ph.D. Title: Formulation and development of transdermal dosage form (Nanoemulsions) for antirheumatoid drug, Jamia Hamdard University, New Delhi, India, 2004-2007. M. Pharm. Title: Development and evaluation of bioadhesive transdermal gels of diclofenac diethylamine, Jamia Hamdard University, New Delhi, India, 2002-2004. B. Pharm., Jamia Hamdard University, New Delhi, India, 1998-2002.

🔬 Practical Experience

Master’s Research Project: Developed bioadhesive transdermal gels for diclofenac diethylamine. Ph.D. Thesis: Developed nanoemulsion and nanoemulsion gel formulations of celecoxib and aceclofenac for arthritis.

🔍Conclusion of Research Projects

Master’s Project: Optimized gel showed controlled drug release and significant anti-inflammatory effects. Ph.D. Thesis: Developed nanoemulsion formulations with controlled release, higher absorption, and significant pharmacodynamic effects.

Publications Top Notes 📝

  • Development and bioavailability assessment of ramipril nanoemulsion formulation
    • Authors: S Shafiq, F Shakeel, S Talegaonkar, FJ Ahmad, RK Khar, M Ali
    • Journal: European journal of pharmaceutics and biopharmaceutics
    • Year: 2007
    • Volume: 66
    • Issue: 2
    • Pages: 227-243
    • Citations: 1006

 

  • Nanoemulsions as vehicles for transdermal delivery of aceclofenac
    • Authors: F Shakeel, S Baboota, A Ahuja, J Ali, M Aqil, S Shafiq
    • Journal: Aaps Pharmscitech
    • Year: 2007
    • Volume: 8
    • Pages: 191-199
    • Citations: 427

 

  • Formulation development and optimization using nanoemulsion technique: a technical note
    • Authors: S Shafiq-un-Nabi, F Shakeel, S Talegaonkar, J Ali, S Baboota, A Ahuja, …
    • Journal: AAPS pharmscitech
    • Year: 2007
    • Volume: 8
    • Pages: E12-E17
    • Citations: 420

 

  • Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib
    • Authors: S Baboota, F Shakeel, A Ahuja, J Ali, S Shafiq
    • Journal: Acta pharmaceutica
    • Year: 2007
    • Volume: 57
    • Issue: 3
    • Pages: 315-332
    • Citations: 397

 

  • A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives
    • Authors: A Muheem, F Shakeel, MA Jahangir, M Anwar, N Mallick, GK Jain, …
    • Journal: Saudi Pharmaceutical Journal
    • Year: 2016
    • Volume: 24
    • Issue: 4
    • Pages: 413-428
    • Citations: 384